# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001757064-25-000010
Filing Date
2025-09-22
Accepted
2025-09-22 16:20:19
Documents
8
Period of Report
2025-09-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | a1gnft-6xkfrontpageword202.htm | 6-K | 27109
2 | EX-99.1 | a12025-rfs6kxgenfit.htm | EX-99.1 | 1469631
3 |  | a0logogenfitwhiteprotectio.jpg | GRAPHIC | 64716
4 |  | a3franchisesen.jpg | GRAPHIC | 1173918
5 |  | image.jpg | GRAPHIC | 288551
6 |  | image_2.jpg | GRAPHIC | 25156
7 |  | logo.jpg | GRAPHIC | 131501
8 |  | pipelineen.jpg | GRAPHIC | 488617
| Complete submission text file | 0001757064-25-000010.txt |  | 4482819

Mailing Address PARC EURASANTE 885, AVENUE EUGENE AVINEE LOOS I0 59120
Business Address PARC EURASANTE 885, AVENUE EUGENE AVINEE LOOS I0 59120 33 3 20 16 4000
Genfit S.A. (Filer) CIK: 0001757064 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38844 | Film No.: 251330259
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)